What is current practice

Despite the lack of conclusive evidence that screening can reduce mortality, there has been widespread introduction of screening for familial ovarian cancer in women aged over 35 years (Vasen et al., 1998). This has led a number of groups (UK Committee for Co-ordinating Cancer Research, the French National Ad Hoc Committee, 1999, and the NIH Consensus Conference, 1995) to recommend the use of defined screening strategies for familial ovarian cancer within the context of clinical trials.

Was this article helpful?

0 0

Post a comment